Display options
Cite
Castejón-Vega B, Rubio A, Pérez-Pulido AJ, et al. L-Arginine Ameliorates Defective Autophagy in GM2 Gangliosidoses by mTOR Modulation. Cells. 2021;10(11)doi: 10.3390/cells10113122.
Castejón-Vega, B., Rubio, A., Pérez-Pulido, A. J., Quiles, J. L., Lane, J. D., Fernández-Domínguez, B., Cachón-González, M. B., Martín-Ruiz, C., Sanz, A., Cox, T. M., Alcocer-Gómez, E., & Cordero, M. D. (2021). L-Arginine Ameliorates Defective Autophagy in GM2 Gangliosidoses by mTOR Modulation. Cells, 10(11), . https://doi.org/10.3390/cells10113122
Castejón-Vega, Beatriz, et al. "L-Arginine Ameliorates Defective Autophagy in GM2 Gangliosidoses by mTOR Modulation." Cells vol. 10,11 (2021). doi: https://doi.org/10.3390/cells10113122
Castejón-Vega B, Rubio A, Pérez-Pulido AJ, Quiles JL, Lane JD, Fernández-Domínguez B, Cachón-González MB, Martín-Ruiz C, Sanz A, Cox TM, Alcocer-Gómez E, Cordero MD. L-Arginine Ameliorates Defective Autophagy in GM2 Gangliosidoses by mTOR Modulation. Cells. 2021 Nov 11;10(11). doi: 10.3390/cells10113122. PMID: 34831346; PMCID: PMC8619250.
Copy Download .nbib Format: NLM
Share it on

Cells. 2021 Nov 11;10(11). doi: 10.3390/cells10113122.

L-Arginine Ameliorates Defective Autophagy in GM2 Gangliosidoses by mTOR Modulation.

Cells

Beatriz Castejón-Vega, Alejandro Rubio, Antonio J Pérez-Pulido, José L Quiles, Jon D Lane, Beatriz Fernández-Domínguez, María Begoña Cachón-González, Carmen Martín-Ruiz, Alberto Sanz, Timothy M Cox, Elísabet Alcocer-Gómez, Mario D Cordero

Affiliations

  1. Research Laboratory, Oral Medicine Department, University of Sevilla, 41009 Sevilla, Spain.
  2. Centro Andaluz de Biologia del Desarrollo (CABD, UPO-CSIC-JA), Facultad de Ciencias Experimentales (Área de Genética), Universidad Pablo de Olavide, 41013 Sevilla, Spain.
  3. Department of Physiology, Institute of Nutrition and Food Technology "José Mataix Verdú", Biomedical Research Center, University of Granada, 18071 Granada, Spain.
  4. Cell Biology Laboratories, School of Biochemistry, University of Bristol, Bristol BS8 1TD, UK.
  5. Acción y Cura Para Tay-Sachs (ACTAYS), 28220 Madrid, Spain.
  6. Department of Medicine, University of Cambridge, Cambridge CB2 0QQ, UK.
  7. Biosciences Institute, Newcastle University, Newcastle upon Tyne NE4 5 PL, UK.
  8. Institute of Molecular, Cell and Systems Biology, University of Glasgow, Glasgow G12 8QQ, UK.
  9. Departamento de Psicología Experimental, Facultad de Psicología, Universidad de Sevilla, 41009 Seville, Spain.
  10. Instituto de Investigación e Innovación en Ciencias Biomédicas de Cádiz (INiBICA), 11009 Cadiz, Spain.
  11. CIBER de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, 28220 Madrid, Spain.

PMID: 34831346 PMCID: PMC8619250 DOI: 10.3390/cells10113122

Abstract

AIMS: Tay-Sachs and Sandhoff diseases (GM2 gangliosidosis) are autosomal recessive disorders of lysosomal function that cause progressive neurodegeneration in infants and young children. Impaired hydrolysis catalysed by β-hexosaminidase A (HexA) leads to the accumulation of GM2 ganglioside in neuronal lysosomes. Despite the storage phenotype, the role of autophagy and its regulation by mTOR has yet to be explored in the neuropathogenesis. Accordingly, we investigated the effects on autophagy and lysosomal integrity using skin fibroblasts obtained from patients with Tay-Sachs and Sandhoff diseases.

RESULTS: Pathological autophagosomes with impaired autophagic flux, an abnormality confirmed by electron microscopy and biochemical studies revealing the accelerated release of mature cathepsins and HexA into the cytosol, indicating increased lysosomal permeability. GM2 fibroblasts showed diminished mTOR signalling with reduced basal mTOR activity. Accordingly, provision of a positive nutrient signal by L-arginine supplementation partially restored mTOR activity and ameliorated the cytopathological abnormalities.

INNOVATION: Our data provide a novel molecular mechanism underlying GM2 gangliosidosis. Impaired autophagy caused by insufficient lysosomal function might represent a new therapeutic target for these diseases.

CONCLUSIONS: We contend that the expression of autophagy/lysosome/mTOR-associated molecules may prove useful peripheral biomarkers for facile monitoring of treatment of GM2 gangliosidosis and neurodegenerative disorders that affect the lysosomal function and disrupt autophagy.

Keywords: GM2 gangliosidosis; L-arginine; autophagy; mTOR

References

  1. PLoS One. 2013 May 17;8(5):e63506 - PubMed
  2. J Clin Invest. 2019 Feb 1;129(2):452-464 - PubMed
  3. J Allergy Clin Immunol. 2018 Oct;142(4):1131-1143.e7 - PubMed
  4. J Lipid Res. 2016 Sep;57(9):1644-58 - PubMed
  5. J Biol Chem. 2004 Apr 2;279(14):13478-87 - PubMed
  6. Traffic. 2018 Dec;19(12):918-931 - PubMed
  7. EMBO Mol Med. 2013 May;5(5):691-706 - PubMed
  8. Nat Rev Mol Cell Biol. 2013 Mar;14(3):133-9 - PubMed
  9. Proc Natl Acad Sci U S A. 2010 Mar 9;107(10):4764-9 - PubMed
  10. Science. 2009 Jul 24;325(5939):473-7 - PubMed
  11. Cancer Res. 2011 Dec 15;71(24):7481-9 - PubMed
  12. Hum Mol Genet. 2015 Apr 1;24(7):1856-68 - PubMed
  13. Aging Cell. 2016 Feb;15(1):77-88 - PubMed
  14. Cell Res. 2014 Jan;24(1):69-79 - PubMed
  15. J Biol Chem. 2006 Jul 21;281(29):20483-93 - PubMed
  16. Front Endocrinol (Lausanne). 2014 Jul 30;5:127 - PubMed
  17. J Cell Sci. 2016 Jul 1;129(13):2475-81 - PubMed
  18. EMBO Mol Med. 2017 Mar;9(3):353-370 - PubMed
  19. Cell Rep. 2013 Dec 12;5(5):1302-15 - PubMed
  20. Hum Mutat. 2017 May;38(5):471-484 - PubMed
  21. Am J Pathol. 2007 Sep;171(3):962-75 - PubMed
  22. EMBO J. 2012 Mar 7;31(5):1095-108 - PubMed
  23. Autophagy. 2017 Apr 3;13(4):642-653 - PubMed
  24. Autophagy. 2016;12(1):1-222 - PubMed
  25. Front Physiol. 2018 Nov 20;9:1663 - PubMed
  26. Curr Gene Ther. 2018;18(2):68-89 - PubMed
  27. Mol Genet Metab. 2015 Feb;114(2):274-80 - PubMed
  28. Curr Biol. 2012 Sep 11;22(17):1616-21 - PubMed
  29. Neurology. 2015 Oct 20;85(16):1368-75 - PubMed
  30. Am J Cancer Res. 2012;2(2):214-21 - PubMed
  31. Autophagy. 2015;11(12):2375-6 - PubMed
  32. Hum Mutat. 2008 Jan;29(1):6-13 - PubMed
  33. EMBO Rep. 2017 Oct;18(10):1727-1739 - PubMed
  34. Nature. 1960 Dec 17;188:1000-2 - PubMed
  35. Orphanet J Rare Dis. 2016 Dec 1;11(1):162 - PubMed

Publication Types

Grant support